155 related articles for article (PubMed ID: 21058665)
1. Nicotinic acetylcholine receptor efficacy and pharmacological properties of 3-(substituted phenyl)-2β-substituted tropanes.
Carroll FI; Blough BE; Mascarella SW; Navarro HA; Eaton JB; Lukas RJ; Damaj MI
J Med Chem; 2010 Dec; 53(23):8345-53. PubMed ID: 21058665
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.
Carroll FI; Muresan AZ; Blough BE; Navarro HA; Mascarella SW; Eaton JB; Huang X; Damaj MI; Lukas RJ
J Med Chem; 2011 Mar; 54(5):1441-8. PubMed ID: 21319801
[TBL] [Abstract][Full Text] [Related]
3. High affinity α3β4 nicotinic acetylcholine receptor ligands AT-1001 and AT-1012 attenuate cocaine-induced conditioned place preference and behavioral sensitization in mice.
Khroyan TV; Yasuda D; Toll L; Polgar WE; Zaveri NT
Biochem Pharmacol; 2015 Oct; 97(4):531-541. PubMed ID: 26256075
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs.
Damaj MI; Slemmer JE; Carroll FI; Martin BR
J Pharmacol Exp Ther; 1999 Jun; 289(3):1229-36. PubMed ID: 10336510
[TBL] [Abstract][Full Text] [Related]
6. α-Conotoxin TxID and [S9K]TxID, α3β4 nAChR Antagonists, Attenuate Expression and Reinstatement of Nicotine-Induced Conditioned Place Preference in Mice.
Li X; You S; Xiong J; Qiao Y; Yu J; Zhangsun D; Luo S
Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33339145
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Nicotinic Acetylcholine Receptor Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(substituted thiophenyl)deschloroepibatidine Analogues.
Ondachi PW; Castro AH; Sherman B; Luetje CW; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
ACS Chem Neurosci; 2017 Jan; 8(1):115-127. PubMed ID: 27726337
[TBL] [Abstract][Full Text] [Related]
8. [¹²⁵I]AT-1012, a new high affinity radioligand for the α3β4 nicotinic acetylcholine receptors.
Wu J; Perry DC; Bupp JE; Jiang F; Polgar WE; Toll L; Zaveri NT
Neuropharmacology; 2014 Feb; 77():193-9. PubMed ID: 24095990
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.
Lukas RJ; Muresan AZ; Damaj MI; Blough BE; Huang X; Navarro HA; Mascarella SW; Eaton JB; Marxer-Miller SK; Carroll FI
J Med Chem; 2010 Jun; 53(12):4731-48. PubMed ID: 20509659
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and nicotinic acetylcholine receptor in vitro and in vivo pharmacological properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues of 2'-fluoro-3'-(4-nitrophenyl)deschloroepibatidine.
Ondachi P; Castro A; Luetje CW; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
J Med Chem; 2012 Jul; 55(14):6512-22. PubMed ID: 22742586
[TBL] [Abstract][Full Text] [Related]
11. Bupropion is a nicotinic antagonist.
Slemmer JE; Martin BR; Damaj MI
J Pharmacol Exp Ther; 2000 Oct; 295(1):321-7. PubMed ID: 10991997
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes.
Carroll FI; Hu X; Navarro HA; Deschamps J; Abdrakhmanova GR; Damaj MI; Martin BR
J Med Chem; 2006 Jun; 49(11):3244-50. PubMed ID: 16722642
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(3'-substituted isoxazol-5-yl)tropanes.
Carroll FI; Pawlush N; Kuhar MJ; Pollard GT; Howard JL
J Med Chem; 2004 Jan; 47(2):296-302. PubMed ID: 14711303
[TBL] [Abstract][Full Text] [Related]
14. Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.
Ortiz NC; O'Neill HC; Marks MJ; Grady SR
Nicotine Tob Res; 2012 Jun; 14(6):711-9. PubMed ID: 22241831
[TBL] [Abstract][Full Text] [Related]
15. AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.
Toll L; Zaveri NT; Polgar WE; Jiang F; Khroyan TV; Zhou W; Xie XS; Stauber GB; Costello MR; Leslie FM
Neuropsychopharmacology; 2012 May; 37(6):1367-76. PubMed ID: 22278092
[TBL] [Abstract][Full Text] [Related]
16. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
Miller DK; Sumithran SP; Dwoskin LP
J Pharmacol Exp Ther; 2002 Sep; 302(3):1113-22. PubMed ID: 12183670
[TBL] [Abstract][Full Text] [Related]
17. Nicotinic receptor antagonists as treatments for nicotine abuse.
Crooks PA; Bardo MT; Dwoskin LP
Adv Pharmacol; 2014; 69():513-51. PubMed ID: 24484986
[TBL] [Abstract][Full Text] [Related]
18. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
Rollema H; Hurst RS
Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of selective agonists for the α7 nicotinic acetylcholine receptor with in situ click-chemistry on acetylcholine-binding protein templates.
Yamauchi JG; Gomez K; Grimster N; Dufouil M; Nemecz A; Fotsing JR; Ho KY; Talley TT; Sharpless KB; Fokin VV; Taylor P
Mol Pharmacol; 2012 Oct; 82(4):687-99. PubMed ID: 22784805
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
Papke RL; Trocmé-Thibierge C; Guendisch D; Al Rubaiy SA; Bloom SA
J Pharmacol Exp Ther; 2011 May; 337(2):367-79. PubMed ID: 21285282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
